Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Cholinesterase inhibitors for Alzheimer's disease
J. Grutzendler
,
J. C. Morris
Department of Neurology
Institute of Clinical and Translational Sciences (ICTS)
Hope Center for Neurological Disorders
Research output
:
Contribution to journal
›
Review article
›
peer-review
267
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cholinesterase inhibitors for Alzheimer's disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alzheimer's Disease
100%
Acetylcholinesterase Inhibitors (AChEI)
100%
Adverse Effects
12%
Potential Gains
12%
Safety Profile
12%
Moderate to Severe
12%
U.S. Food
12%
Clinical Experience
12%
Public Health Risk
12%
New Drugs
12%
Primary Therapy
12%
Acetylcholine
12%
Cognitive Status
12%
Neurobiology
12%
Pharmacology
12%
Central Synapses
12%
Donepezil
12%
Rivastigmine
12%
Age-related Neurodegeneration
12%
Galantamine
12%
Tacrine
12%
Metrifonate
12%
Effectivenes
12%
Neuroscience
Alzheimer's Disease
100%
Acetylcholinesterase Inhibitor
100%
Adverse Effect
12%
Neurodegenerative Disorder
12%
Synapse
12%
Behavior (Neuroscience)
12%
Acetylcholine
12%
Neuroscience
12%
Donepezil
12%
Rivastigmine
12%
Galantamine
12%
Tacrine
12%
Metrifonate
12%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Cholinesterase Inhibitor
100%
Acetylcholine
12%
Degenerative Disease
12%
Clinical Pharmacology
12%
Donepezil
12%
Rivastigmine
12%
Galantamine
12%
Tacrine
12%
Metrifonate
12%
Diseases
12%